The latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...

The current approval of Takeda’s Takhzyro pre-filled pen is an addition to the existing 150 mg and 300 mg pre-filled syringes ...

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

NexoBrid ® is a topically administered biological orphan drug that enzymatically removes eschar while preserving viable ...

Paul Chaplin, President and CEO of Bavarian Nordic said, "We are pleased to announce our first collaboration to expand global access to our Chikungunya Vaccine and also our first partnership with ...

Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") of a class action securities lawsuit. CLASS ...

Nick Alves was 19 when a psychiatrist offered him the antidepressant Trintellix to treat his moderate anxiety and depression ...

The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...

Biological E partners with Bavarian Nordic to manufacture chikungunya vaccine in developing nations Hyderabad: Biological E ...